STLN
The Oncology Institute, Inc.
6.30$
-0.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 49.8% | 68.6% | 65.1% | 68.5% | |
| 5.4% | 16.0% | 28.8% | 20.4% | |
| – | – | – | 20.4% | |
| 15.2% | 20.2% | 28.0% | 36.0% | |
| 3.5% | 6.5% | 5.8% | 10.2% | |
| 8.2% | 3.5% | 4.2% | 4.4% | |
| 6.9% | 8.6% | 8.6% | 6.7% | |
| 52.9% | 72.7% | 97.9% | 109.5% | |
| 11.4% | 16.6% | 30.2% | 43.1% | |
| – | – | – | 4.3% | |
| 3.6% | 6.9% | 14.1% | 26.2% | |
| 30.8% | 41.5% | 53.9% | 47.0% | |
| 47.1% | 27.3% | 2.1% | -9.5% | |
| -24.1% | -69.8% | -122.1% | -164.8% | |
| 28.0% | 35.4% | 43.9% | 56.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.